We are live on
!
Find out more
Bio-Rad Laboratories Class A
500 hedge funds and large institutions have $9.18B invested in Bio-Rad Laboratories Class A in 2022 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 159 increasing their positions, 202 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
0.54% less ownership
Funds ownership: 77.36% → 76.81% (-0.54%)
8% less first-time investments, than exits
New positions opened: 65 | Existing positions closed: 71
3% less funds holding
Funds holding: 515 → 500 (-15)
14% less capital invested
Capital invested by funds: $10.7B → $9.18B (-$1.55B)
21% less repeat investments, than reductions
Existing positions increased: 159 | Existing positions reduced: 202
63% less call options, than puts
Call options by funds: $41.9M | Put options by funds: $115M
Holders
500
Holders Change
-15
Holders Change %
-2.91%
% of All Funds
8.42%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.13%
New
65
Increased
159
Reduced
202
Closed
71
Calls
$41.9M
Puts
$115M
Net Calls
-$72.7M
Net Calls Change
-$39.1M
Top Buyers
Top Sellers
| 1 |
Marshall Wace
London,
United Kingdom
|
-$126M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$118M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$115M |
| 4 |
BlackRock
New York
|
-$88.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$43.7M |
